Modification of decellularized goat-lung scaffold with chitosan/nanohydroxyapatite composite for bone tissue engineering applications

Biomed Res Int. 2013:2013:651945. doi: 10.1155/2013/651945. Epub 2013 Jun 13.

Abstract

Decellularized goat-lung scaffold was fabricated by removing cells from cadaver goat-lung tissue, and the scaffold was modified with chitosan/nanohydroxyapatite composite for the purpose of bone tissue engineering applications. MTT assay with osteoblasts, seeded over the chitosan/nanohydroxyapatite-modified decellularized scaffold, demonstrated significantly higher cell growth as compared to the decellularized scaffold without modification. SEM analysis of cell-seeded scaffold, after incubation for 7 days, represented a good cell adhesion, and the cells spread over the chitosan/nanohydroxyapatite-modified decellularized scaffold. Expression of bone-tissue-specific osteocalcin gene in the osteoblast cells grown over the chitosan/nanohydroxyapatite-modified decellularized scaffold clearly signifies that the cells maintained their osteoblastic phenotype with the chitosan/nanohydroxyapatite-modified decellularized scaffold. Therefore, it can be concluded that the decellularized goat-lung scaffold-modified with chitosan/nanohydroxyapatite composite, may provide enhanced osteogenic potential when used as a scaffold for bone tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Transplantation
  • Bone and Bones*
  • Cell Adhesion / drug effects
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Chitosan / administration & dosage
  • Chitosan / chemistry*
  • Durapatite / administration & dosage
  • Durapatite / chemistry*
  • Goats / growth & development
  • Goats / physiology
  • Lung / cytology
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry
  • Osteogenesis / drug effects
  • Tissue Engineering*
  • Tissue Scaffolds / chemistry

Substances

  • Chitosan
  • Durapatite